Brazil
Doutor ao Vivo is a health care startup based in Brazil, founded in 2019. It offers a white-label telemedicine platform for health companies to conduct teleconsultations conveniently and securely. The platform enables health insurance companies, clinics, and doctors to engage in telemedicine through video conferencing for teleconsultations, teleorientation, teleinterconsultation, and teletriage.
One of the standout features of Doutor ao Vivo is its white-label model, allowing the platform to be customized with the partner's name and logo. Additionally, it boasts seamless integration with other systems, a Picture-In-Picture plugin for the consultation room, intelligent triage, voice transcribed medical reports, and email prescription delivery. The platform complies with current legislation and market security protocols.
The latest funding round for Doutor ao Vivo occurred on 23 June 2023, with Bossa Invest as the venture round investor. This investment signifies confidence in Doutor ao Vivo's potential to revolutionize the telemedicine industry and cater to the evolving needs of the health care sector.
